SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-18-001841
Filing Date
2018-04-30
Accepted
2018-04-30 17:07:15
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K admp-10ka_123117.htm 10-K/A 644160
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11633
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11835
  Complete submission text file 0001387131-18-001841.txt   668764
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36242 | Film No.: 18791052
SIC: 2834 Pharmaceutical Preparations